ARCTURUS THERAPEUTICS LTD's ticker is ARCT and the CUSIP is M1492T105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $6,332,000 | +71.5% | 927,144 | +13.7% | 0.18% | +20.7% |
Q4 2018 | $3,693,000 | -46.0% | 815,176 | +5.4% | 0.15% | -27.5% |
Q3 2018 | $6,840,000 | +51.1% | 773,772 | +45.0% | 0.21% | +24.7% |
Q2 2018 | $4,526,000 | +148.5% | 533,773 | +61.2% | 0.17% | +84.4% |
Q1 2018 | $1,821,000 | +198.5% | 331,165 | +331.6% | 0.09% | +83.7% |
Q4 2017 | $610,000 | – | 76,737 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 72,805 | $330,000 | 0.16% |
ARK Investment Management | 815,176 | $3,693,000 | 0.15% |
ROYCE & ASSOCIATES LP | 106,436 | $482,000 | 0.00% |
Independence Bank of Kentucky | 607 | $3,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 27,300 | $124,000 | 0.00% |
GROUP ONE TRADING, L.P. | 4,086 | $19,000 | 0.00% |
1832 Asset Management L.P. | 560 | $3,000 | 0.00% |
CITIGROUP INC | 171 | $1,000 | 0.00% |
MORGAN STANLEY | 71,582 | $324,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 5,562 | $25,000 | 0.00% |